{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:22:05Z","timestamp":1770823325550,"version":"3.50.1"},"reference-count":18,"publisher":"Rockefeller University Press","issue":"3","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/rupress.org\/pages\/terms102024\/"}],"funder":[{"DOI":"10.13039\/501100019370","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","award":["2023.14157.PEX"],"award-info":[{"award-number":["2023.14157.PEX"]}],"id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","award":["2021.01953.CEECIND"],"award-info":[{"award-number":["2021.01953.CEECIND"]}],"id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organisation","doi-asserted-by":"publisher","award":["233-2023"],"award-info":[{"award-number":["233-2023"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031585","name":"Takeda Development Center Americas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031585","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"abstract":"<jats:p>Cancer immunotherapy has mostly relied on conventional T cells to achieve success in a limited set of tumor types. A promising avenue to expand the repertoire of cancers effectively treated through immune intervention is to mobilize other anti-tumor effectors, such as \u03b3\u03b4 T cells. Among these, the V\u03b41+ subset commonly predominates within peripheral tissues and within tumors, typically associating with good prognosis. In this Found in Translation, we discuss how to leverage the biological properties of V\u03b41+ \u03b3\u03b4 T cells for cancer immunotherapy, with special focus on the delta one T (DOT) cell approach.<\/jats:p>","DOI":"10.1084\/jem.20252289","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:20:57Z","timestamp":1769066457000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Follow the \u201cDOTs\u201d: V\u03b41+ \u03b3\u03b4 T cells as effectors of cancer immunotherapy"],"prefix":"10.1084","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4141-9302","authenticated-orcid":true,"given":"Bruno","family":"Silva-Santos","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0346k0491","id-type":"ROR","asserted-by":"publisher"}],"name":"Gulbenkian Institute for Molecular Medicine 1 , Lisbon,","place":["Portugal"]},{"name":"Faculdade de Medicina da Universidade de Lisboa 2 , Lisbon,","place":["Portugal"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-0033","authenticated-orcid":true,"given":"Sofia","family":"Mensurado","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0346k0491","id-type":"ROR","asserted-by":"publisher"}],"name":"Gulbenkian Institute for Molecular Medicine 1 , Lisbon,","place":["Portugal"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-8699","authenticated-orcid":true,"given":"Rafael","family":"Blanco-Dom\u00ednguez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0346k0491","id-type":"ROR","asserted-by":"publisher"}],"name":"Gulbenkian Institute for Molecular Medicine 1 , Lisbon,","place":["Portugal"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9495-5793","authenticated-orcid":true,"given":"Adrian C.","family":"Hayday","sequence":"additional","affiliation":[{"name":"King\u2019s College London 3 , London,","place":["UK"]},{"id":[{"id":"https:\/\/ror.org\/04tnbqb63","id-type":"ROR","asserted-by":"publisher"}],"name":"The Francis Crick Institute 4 , London,","place":["UK"]}]}],"member":"291","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2026021109515701200_bib1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0597","author":"Almeida","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"2026021109515701200_bib2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00948-9","author":"Blanco-Dom\u00ednguez","year":"2025","journal-title":"Nat. Cancer"},{"key":"2026021109515701200_bib3","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-7365467\/v1","author":"Blanco-Dom\u00ednguez","year":"2025","journal-title":"Res. Square"},{"key":"2026021109515701200_bib4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-339135","author":"Correia","year":"2011","journal-title":"Blood"},{"key":"2026021109515701200_bib5","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00690-0","author":"Davies","year":"2024","journal-title":"Nat. Cancer"},{"key":"2026021109515701200_bib6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05593-1","author":"de Vries","year":"2023","journal-title":"Nature"},{"key":"2026021109515701200_bib7","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0647","author":"Di Lorenzo","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"2026021109515701200_bib8","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00589-w","author":"Harmon","year":"2023","journal-title":"Nat. Cancer"},{"key":"2026021109515701200_bib9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq7248","author":"Hayday","year":"2024","journal-title":"Science"},{"key":"2026021109515701200_bib10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022992","author":"Mensurado","year":"2024","journal-title":"Blood"},{"key":"2026021109515701200_bib11","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70023","author":"Mohammed","year":"2025","journal-title":"Immunol. Rev."},{"key":"2026021109515701200_bib12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00617","author":"Niu","year":"2018","journal-title":"Front. Immunol."},{"key":"2026021109515701200_bib13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2417","author":"Poggi","year":"2004","journal-title":"Cancer Res."},{"key":"2026021109515701200_bib14","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01448-7","author":"Rancan","year":"2023","journal-title":"Nat. Immunol."},{"key":"2026021109515701200_bib15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005400","author":"S\u00e1nchez Mart\u00ednez","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"2026021109515701200_bib16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22433-4","author":"Weng","year":"2021","journal-title":"Nat. Commun."},{"key":"2026021109515701200_bib17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax9364","author":"Wu","year":"2019","journal-title":"Sci. Transl Med."},{"key":"2026021109515701200_bib18","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00376-z","author":"Wu","year":"2022","journal-title":"Nat. Cancer"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20252289\/2026860\/jem_20252289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20252289\/2026860\/jem_20252289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:52:03Z","timestamp":1770821523000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/223\/3\/e20252289\/281486\/Follow-the-DOTs-V-1-T-cells-as-effectors-of-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20252289","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"article-number":"e20252289"}}